Patent Assignment
Reel/Frame 070434/0319
Amended and Restated Patent Security Agreement
Recorded: 2025-03-06
Pages: 28
Assignor
UROGEN PHARMA LTD.
Executed: 2025-03-05
Assignee
BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(44)
Treatment of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer with a Thermally Gelling Pharmaceutical Composition Containing Mitomycin
Application:
18/784,354 →
Publication:
US 2025/0032409
Immunomodulating Treatments of Body Cavities
Material and Method for Treating Internal Cavities
Application:
18/129,497 →
Publication:
US 2023/0241220
Immunomodulating Treatments of Body Cavities
Application:
18/180,152 →
Publication:
US 2023/0218521
Material and Method for Treating Cancer
Material and Method for Treating Internal Cavities
Oncolytic Adenovirus with Enhanced Replication Properties Comprising Modifications in E1A, E3, and E4
Adenoviral Assembly Method
Application:
17/681,538 →
Publication:
US 2022/0411763
Oncolytic Adenovirus Compositions
Oncolytic Tumor Viruses and Methods of Use
High Throughput Assay for Measuring Adenovirus Replication Kinetics
Application:
18/809,603 →
Publication:
US 2025/0146013
Exogenous Gene Expression in Recombinant Adenovirus for Minimal Impact on Viral Kinetics
Tumor-Targeting Synthetic Adenoviruses and Uses Thereof
Application:
18/478,388 →
Publication:
US 2024/0207445
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Material and Method for Treating Internal Cavities
Material and Method for Treating Internal Cavities
Material and Method for Treating Internal Cavities
Material and Method for Treating Internal Cavities
Biocompatible Drug Delivery Apparatus and Methods
Methods for Treatment of Bladder Cancer
Biocompatible Drug Delivery Apparatus and Methods
Methods for Treatment of Bladder Cancer
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Slow Release Formulations of Cell Cycle Regulators and Anti-Cancer Agents for Local Treatment of Solid Cancer
Patent:
9,801,854 →
Application:
14/600,354 →
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Immunomodulating Treatments of Body Cavities
Thermosensitive Bio-Adhesive Hydrogel for Removal of Ureteral and Renal Stones
A Connectable Catheter
Material and Method for Treating Cancer
Adenoviral Assembly Method
Adenoviral Assembly Method
Oncolytic Adenovirus Compositions
High Throughput Assay for Measuring Adenovirus Replication Kinetics
Exogenous Gene Expression in Therapeutic Adenovirus for Minimal Impact on Viral Kinetics
Exogenous Gene Expression in Recombinant Adenovirus for Minimal Impact on Viral Kinetics
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Antibodies and Methods of Use Thereof
Process for the Preparation of a Freeze-Dried Pharmaceutical Composition Containing Mitomycin C
Process for the Preparation of a Freeze-Dried Pharmaceutical Composition Containing Mitomycin C
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2004
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 015817/0081 →
Assignment of Assignor's Interest
Nov 5, 2012
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 029238/0909 →
Assignment of Assignor's Interest
Jan 9, 2014
From: KONORTY, MARINA; HAKIM, GIL
To: THERACOAT LTD
Reel/Frame 031947/0586 →
Change of Name
Jan 19, 2016
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037553/0678 →
Assignment of Assignor's Interest
Apr 27, 2017
From: O'SHEA, CLODAGH; MIYAKE-STONER, SHIGEKI
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 042160/0554 →
Assignment of Assignor's Interest
Jan 8, 2018
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 044556/0637 →
Change of Name
Jan 8, 2018
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 045016/0287 →
Assignment of Assignor's Interest
Nov 12, 2020
From: O'SHEA, CLODAGH; LYMAN, MICHAEL; PARTLO, WILLIAM; MIYAKE-STONER, SHIGEKI
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 054354/0948 →
Change of Name
Mar 15, 2021
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 055588/0095 →
Security Interest
Apr 8, 2021
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICAV
Reel/Frame 055868/0385 →
Assignment of Assignor's Interest
Jul 12, 2021
From: O'SHEA, CLODAGH; MIYAKE-STONER, SHIGEKI
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 056830/0176 →
Assignment of Assignor's Interest
Feb 25, 2022
From: O'SHEA, CLODAGH; POWERS, COLIN
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 059107/0939 →
Security Interest
Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Assignment of Assignor's Interest
Apr 7, 2022
From: HIONIDI, YULIA; TSIPORI, OMER; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059528/0317 →
Assignment of Assignor's Interest
May 17, 2022
From: WOLCHOK, JEDD DAVID; MERGHOUB, TAHA; SCHAER, DAVID
To: MEMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 059935/0889 →
Assignment of Assignor's Interest
May 17, 2022
From: RITTER, GERD
To: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Reel/Frame 059935/0884 →
Assignment of Assignor's Interest
May 17, 2022
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 059935/0855 →
Assignment of Assignor's Interest
May 17, 2022
From: VAN DIJK, MARC; MUNDT, CORNELIA ANNE
To: 4-ANTIBODY AG
Reel/Frame 059935/0837 →
Assignment of Assignor's Interest
May 17, 2022
From: WILSON, NICHOLAS STUART; SAVITSKY, DAVID ADAM; FINDEIS, MARK ARTHUR
To: AGENUS INC.
Reel/Frame 059935/0825 →
Amended and Restated Patent Security Agreement
May 19, 2022
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICA V
Reel/Frame 060121/0591 →
Assignment of Assignor's Interest
Jun 29, 2022
From: O'SHEA, CLODAGH; PARTLO, WILLIAM; POWERS, COLIN
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 060359/0363 →
Assignment of Assignor's Interest
Mar 23, 2023
From: HAKIM, GIL; STRAUSS-AYALI, DALIT; FRIEDMAN, ASTAR; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 063072/0794 →
Patent Security Agreement
Aug 18, 2023
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064641/0263 →
Assignment of Assignor's Interest
Oct 2, 2023
From: O'SHEA, CLODAGH; POWERS, COLIN; ZHANG, LEI
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 065088/0382 →
Patent Security Agreement
Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →